Multidomain Biologics: Bioanalytical Strategies and Insights, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn strategies for developing bioanalytical assays for multidomain biologics. Attendees will gain insights into the pharmacokinetic and immunogenicity analysis of multidomain biologics. The featured speakers will also share case studies showing the different approaches used for these complex biotherapeutics.

TORONTO, Aug. 21, 2025 /PRNewswire/ — Due to their complex nature, multidomain biologics present unique bioanalytical challenges. This class of biotherapeutics is broadly defined as therapies composed of two or more distinct domains, each with a specific mechanism of action. This structural complexity offers the potential for increased efficacy compared to traditional monoclonal antibody therapies, which typically function through a single mechanism. However, the presence of multiple domains adds complexity to bioanalytical assays used to assess the safety and efficacy of these therapies. The multimodal nature of multidomain biologics necessitates specialized strategies for assay design and validation to ensure that all components of the biologic are captured in the final analytical output.

In this webinar, the featured speakers will share key insights into the development and validation of pharmacokinetic and immunogenicity assays tailored for multidomain biologics. Attendees will learn how to employ a single assay to characterize the therapeutic profile and determine when additional molecular characterization should be incorporated throughout the clinical development timeline.

Register now to discover best practices for developing and validating bioanalytical assays that support the successful advancement of multidomain biologics.

Join experts from BioAgilytix, Lynn Kamen, Scientific Officer, Executive Director; and Christopher Tiedje, Associate Director and Principal Investigator; Joshua Cubbison, Manager II of Bioanalytical Operations; and Liz Nolff, MS, Manager II of Bioanalytical Operations, for the live webinar on Monday, September 8, 2025, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Multidomain Biologics: Bioanalytical Strategies and Insights.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/multidomain-biologics-bioanalytical-strategies-and-insights-upcoming-webinar-hosted-by-xtalks-302535284.html

SOURCE Xtalks

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

3 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

5 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

5 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

5 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

5 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

5 hours ago